Sorafenib

myeloid cell leukemia sequence 1 ; Mus musculus







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31337603 PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy. 2019 Oct 2 1
2 27307592 Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). 2016 Dec 15 1
3 24852430 Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo. 2014 Aug 1
4 23231952 Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma. 2013 Feb 1 1
5 22406995 Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. 2012 May 1
6 22446485 Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. 2012 Jun 21 1
7 22952216 Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model. 2012 Oct 15 3
8 20015197 Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. 2011 Feb 1
9 20884624 Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. 2010 Nov 1 1
10 17595328 The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. 2007 Sep 1